A study by UK and Swedish researchers found that male Swedish farmers have a significantly lower risk of hip fracture, possibly due to their high levels of physical activity. The researchers analyzed data from Sweden's national registry and found that farming was associated with a 39% lower risk of hip fracture.
The IOF President's Award was presented to eight leading regional osteoporosis experts and advocates for their contributions to global osteoporosis awareness and education. The recipients were recognized for their outstanding work in the field, including Dr Ambrish Mithal, Prof Patricia Clark, and Prof Jorge Cannata Andia.
A new study presents data demonstrating that personalized direct-acting antiviral treatment can eradicate the hepatitis C virus from the body in patients who had previously failed treatment. The study identified effective re-treatment combinations for genotype 1 and 3, achieving SVR12 rates of 90% and 100%, respectively.
A Phase 1 study found that NVR 3-778, a first-in-class HBV capsid assembly inhibitor, is well-tolerated when combined with pegylated interferon. The treatment reduced levels of hepatitis B more than NVR 3-778 alone, with the largest reduction seen in the combination group.
A recent study reveals that sarcopenia is expected to significantly increase in Europe, affecting up to 19 million seniors. The prevalence of sarcopenia will rise from 11.1% in 2016 to 12.9% by 2045, with women accounting for a majority of cases.
Scientists have created T cells that can recognize and destroy cancer cells in pancreatic tumors. The engineered cells were able to attack tumor cells for up to 10 days without harming healthy tissues.
Research shows that patients with total knee replacement due to primary osteoarthritis have a low risk of hip and vertebral fractures before and after surgery. However, the risk increases by 19% for vertebral fracture and 4% for hip fracture in the years following surgery.
A UK study found no link between calcium supplementation, with or without vitamin D, and hospital admissions or mortality due to cardiovascular events. The analysis of the UK Biobank dataset showed that calcium supplementation did not increase the risk of future cardiac events.
A recent study by Dr. Barbro Kjellström found that heart attack patients are more likely to be depressed, with 14% experiencing symptoms compared to 7% of control group members. However, antidepressants were prescribed less frequently among heart attack patients with depression, at just 16%, compared to 42% of control group members.
A new study presents Norursodeoxycholic acid as a viable treatment option for patients with primary sclerosing cholangitis, a rare condition characterized by inflammation and scarring in the bile ducts. The treatment significantly reduced levels of serum alkaline phosphatase and had similar rates of adverse events compared to placebo.
A new study finds that generic direct-acting antiviral treatment for Hepatitis C can deliver high sustained virologic response rates comparable to branded treatments, but at a significantly lower price. The results suggest that generic DAAs could support access to treatment in many countries where it is currently unaffordable.
A new study reveals high levels of hepatitis B markers among unvaccinated refugee populations in northern Germany, highlighting a significant public health concern. The research found that nearly one million asylum applications were lodged in Germany last year, with many coming from unstable states where health systems have broken down.
A pilot study found that a direct-acting antiviral treatment over six weeks can effectively cure acute hepatitis C in patients. The treatment resulted in undetectable HCV levels and sustained virologic response after a 12-week follow-up, with side effects including fatigue.
A new study published at The International Liver Congress 2016 found that the diabetes drug sitagliptin was no more effective than placebo in reducing non-alcoholic fatty liver disease. However, researchers demonstrated that non-invasive imaging techniques based on MRI were useful for measuring changes in liver fat and fibrosis.
A new study has demonstrated the efficacy of all-oral treatment regimens in adolescents with hepatitis C virus. The study found that 97% of patients achieved sustained virologic response rates after 12 weeks of treatment, suggesting a promising treatment option for this patient group.
ABT-493 and ABT-530 achieved 100% sustained virologic response (SVR12) in cirrhotic patients, while non-cirrhotic patients showed a 97% SVR12 rate after eight weeks. This treatment offers hope for genotype 3 patients with heavily scarred livers.
A new study demonstrates that a build-up of fat around the waist can cause more serious complications than obesity in the development of non-alcoholic fatty liver disease (NAFLD). Non-obese patients with a large waist circumference are at risk of NAFLD complications, according to the research. The study highlights the need for addition...